salesforce.com (CRM) PT Raised to $310 at Oppenheimer

'A Must Own Asset for Growth Investors': Piper Upgrades Salesforce (CRM) to Overweight, Says There's Room for 30% Gains

Shares of Salesforce.com (NYSE: CRM) are up 2% today to print new record highs after Piper Sandler analyst Brent Bracelin upgraded to Overweight from Neutral.

Following conversations with the leadership, the analyst is confident investors could see a multi-year period of multiple and profit expansion on the back of the operating discipline and organic investments that can scale growth.

We came away from in-person meetings at the Dreamforce analyst day encouraged by the commitment, desire, and dedication... More

salesforce.com (CRM) PT Raised to $328 at Monness, Crespi, Hardt

Monness, Crespi, Hardt analyst Brian White raised the price target on salesforce.com (NYSE: CRM) to $328.00 (from $300.00) while maintaining a Buy rating.

salesforce.com (CRM) PT Raised to $330 at BofA Securities

BofA Securities analyst Brad Sills raised the price target on salesforce.com (NYSE: CRM) to $330.00 (from $320.00) while maintaining a Buy rating.

salesforce.com (CRM) PT Raised to $315 at Cantor Fitzgerald

Cantor Fitzgerald analyst David Hynes Jr. raised the price target on salesforce.com (NYSE: CRM) to $315.00 (from $305.00) while maintaining an Overweight rating following the company's Analyst Day.

The analyst commented, "Salesforce shares were strong on Thursday on the back of an Analyst Day in which the positives meaningfully outweighed any questions left unanswered. On the positive side, updated guidance and an above consensus... More

salesforce.com (CRM) PT Raised to $350 at Stifel

Stifel analyst Parker Lane raised the price target on salesforce.com (NYSE: CRM) to $350.00 (from $315.00) while maintaining a Buy rating.

The analyst commented, "Salesforce wrapped up its 2021 Dreamforce conference with its annual Investor Day on Thursday. With management's updated financial targets... More